✦ LIBER ✦

Considerable plasma levels of a cytotoxic etoposide metabolite in patients undergoing high-dose chemotherapy

✍ Scribed by S. Stremetzne; U. Jaehde; R. Kasper; J. Beyer; W. Siegert; W. Schunack

Book ID: 117663834
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 142 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)00087-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of etoposide in patients unde

Metabolism of etoposide in patients undergoing high-dose chemotherapy

✍ S. Stremetzne; U. Jaehde; R. Kaper; J. Beyer; W. Siegert; W. Schnunack 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 54 KB

High-dose chemotherapy with etoposide, c

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

✍ Ibrahim, Amad; Zambon, Edmilson; Bourhis, Jean H.; Ostronoff, Maurice; Beaujean, 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 844 KB

Midpoint CD34 measurement as a predictor

Midpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy

✍ Rameshwar S. Sidhu; Edmund Orsini Jr.; Roger Giller; Ralph Quinones; Nicholas K. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

High-dose chemo/radiotherapy of sensitive tumors requires PBPC rescue doses of >3•10 6 CD34/kg (range: 3-20•10 6 CD34/kg). Because of the diversity of stem cell treatment protocols and clinical presentation of patients at the time of peripheral blood progenitor cell (PBPC) harvest, the use of the mi

Evaluation of acute toxicities associate

Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy

✍ Ferrucci, P F; Martinoni, A; Cocorocchio, E; Civelli, M; Cinieri, S; Cardinale, 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Gas chromatography-mass spectrometry ide

Gas chromatography-mass spectrometry identification of a novel N3-methylated metabolite of 5′-deoxy-5-fluorouridine in plasma of cancer patients undergoing chemotherapy

✍ Carlo G. Zambonin; Francesco Palmisano 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 529 KB

A phase I/II study of oral etoposide and

A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy

✍ Michael Fiegl; Thomas Büchner; Wolfgang Hiddemann; Jan Braess 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 84 KB